Detalhe da pesquisa
1.
Genetic and phenotypic attributes of splenic marginal zone lymphoma.
Blood
; 139(5): 732-747, 2022 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34653238
2.
Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia.
Blood
; 138(7): 571-583, 2021 08 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33889952
3.
Eltrombopag second-line therapy in adult patients with primary immune thrombocytopenia in an attempt to achieve sustained remission off-treatment: results of a phase II, multicentre, prospective study.
Br J Haematol
; 193(2): 386-396, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33618438
4.
Eltrombopag for immune thrombocytopenia secondary to chronic lymphoproliferative disorders: a phase 2 multicenter study.
Blood
; 134(20): 1708-1711, 2019 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31570488
5.
Rituximab in the treatment of immune thrombocytopenia: what is the role of this agent in 2019?
Haematologica
; 104(6): 1124-1135, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31126963
6.
Teclistamab salvage therapy for multiple myeloma relapse after allogeneic hemopoietic stem cell transplant: A case report.
Am J Hematol
; 99(1): E29-E31, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38032813
7.
Successful treatment and FDG-PET/CT monitoring of HHV-6 encephalitis in a non-neutropenic patient: case report and literature review.
J Neurovirol
; 23(6): 908-912, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28822107
8.
Rituximab in immune thrombocytopenia: gender, age, and response as predictors of long-term response.
Eur J Haematol
; 98(4): 371-377, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27981682
9.
Short course of bortezomib in anemic patients with relapsed cold agglutinin disease: a phase 2 prospective GIMEMA study.
Blood
; 132(5): 547-550, 2018 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29898955
10.
Serological and cellular response to mRNA-SARS-CoV2 vaccine in patients with hematological lymphoid malignancies: Results of the study "Cervax".
Front Oncol
; 13: 1133348, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36923438
11.
Nationwide Survey on the Use of Thrombopoietin Receptor Agonists (TPO-RA) for the Management of Immune Thrombocytopenia in Current Clinical Practice in Italy.
Mediterr J Hematol Infect Dis
; 15(1): e2023019, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36908864
12.
Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the Fondazione Italiana Linfomi MCL0208 trial.
Blood Adv
; 7(14): 3764-3774, 2023 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37058477
13.
Venetoclax in combination with hypomethylating agents in previously untreated patients with acute myeloid leukemia ineligible for intensive treatment: a real-life multicenter experience.
Leuk Res
; 114: 106803, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35150967
14.
Case report: Long-lasting SARS-CoV-2 infection with post-COVID-19 condition in two patients with chronic lymphocytic leukemia: The emerging therapeutic role of casirivimab/imdevimab.
Front Oncol
; 12: 945060, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36249044
15.
Real-world Outcomes of Relapsed/Refractory Diffuse Large B-cell Lymphoma Treated With Polatuzumab Vedotin-based Therapy.
Hemasphere
; 6(12): e798, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36398133
16.
Case Report: Cardiac Involvement by Lymphoma: Rare but Heterogeneous Condition With Challenging Behaviors.
Front Oncol
; 11: 665736, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33987101
17.
Immune checkpoint inhibitors in combination with radiotherapy as salvage treatment for relapsed/refractory classical Hodgkin lymphoma: A retrospective analysis in 12 patients.
Hematol Rep
; 13(2): 9080, 2021 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34221295
18.
Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma.
Cancers (Basel)
; 13(23)2021 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34885198
19.
Venetoclax Shows Low Therapeutic Activity in BCL2-Positive Relapsed/Refractory Peripheral T-Cell Lymphoma: A Phase 2 Study of the Fondazione Italiana Linfomi.
Front Oncol
; 11: 789891, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34938664
20.
Limited efficacy for ibrutinib and venetoclax in T-prolymphocytic leukemia: results from a phase 2 international study.
Blood Adv
; 8(4): 842-845, 2024 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38190628